Trazimera

Medicinal product

(Invented) name

Trazimera

Active substance (s)

Trastuzumabas

Strength

150 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FD01, trastuzumab

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2018-08-16

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Trastuzumabas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99980	86088	1086088	flakonas	N1		Receptinis	EU/1/18/1295/001	Netiekiama	2025-01-01	2025-12-31	Yes	2025-01-02	2025-12-31

Stadijos

Data	Stadija
2018-08-16	Registruotas